[April 01, 2016]

Atrial Fibrillation Development Therapeutics Pipeline Review, H1 2016 - Research and Markets

Research and Markets has announced the addition of the "Atrial Fibrillation - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Atrial Fibrillation and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
2. Atrial Fibrillation Overview
3. Therapeutics Development
4. Pipeline Products for Atrial Fibrillation - Overview
5. Pipeline Products for Atrial Fibrillation - Comparative Analysis
6. Atrial Fibrillation - Therapeutics under Development by Companies
7. Atrial Fibrillation - Therapeutics under Investigation by Universities/Institutes
8. Atrial Fibrillation Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Atrial Fibrillation - Products under Development by Companies
13. Atrial Fibrillation - Products under Investigation by Universities/Institutes
14. Atrial Fibrillation - Companies Involved in Therapeutics Development

• ARCA biopharma, Inc.
• AstraZeneca Plc
• Bristol-Myers Squibb Company
• Cardiome Pharma Corp.
• Daiichi Sankyo Company, Limited
• Gilead Sciences, Inc.
• Ionis Pharmaceuticals, Inc.
• Laboratoires Pierre Fabre SA
• Nissan Chemical Industries, Ltd.
• Nyken B.V.
• Otsuka Holdings Co., Ltd.
• Perrigo Company Plc
• Xention Limited

For more information visit http://www.researchandmarkets.com/research/ptpn8v/atrial

View source version on businesswire.com: http://www.businesswire.com/news/home/20160401005433/en/

[ Back To TMCnet.com's Homepage ]